优先审评公示*CDE

The CDE (Center for Drug Evaluation) website is a comprehensive resource for information on drug evaluation and approval in China. The site provides information on the CDE's mission, organization, and activities, as well as a searchable database of all drugs that have been approved for marketing in China. One of the most important features of the CDE website is the "Priority Review Announcement" section, which provides information on drugs that have been granted priority review status by the CDE. Priority review status is granted to drugs that are intended to treat serious or life-threatening conditions, and it allows these drugs to be evaluated more quickly than drugs that are not granted priority review status. The CDE website also provides information on the CDE's drug approval process, including the submission requirements, review timelines, and approval criteria. This information is essential for companies that are developing drugs for the Chinese market. Overall, the CDE website is a valuable resource for information on drug evaluation and approval in China. The site provides a wealth of information on the CDE's mission, organization, activities, and drug approval process. This information is essential for companies that are developing drugs for the Chinese market, as well as for patients and consumers who are interested in learning more about the drugs that are available in China.